Revenue for 1H FY2026 was NZ$860k, down 17% year-over-year due to deferred sales, but full-year guidance remains at NZ$2.8m. Strategic alliances, new distributors, and public screening programs in key markets are expected to drive growth and positive cash flow by late FY2026.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.